Notice Information
Notice Title
EC0810 Clinical trial formulation, Anne Rowling Clinic
Notice Description
Double blind randomised clinical IMP trial- Manufacture of liquid form of 2 active ingredients and matching placebo, provision of dossier for MHRA application and approval, labelling, storage and distribution of the IMP and placebo as required.
Lot Information
Lot 1
Tender for the manufacturing, packaging, labelling, shipping and storage of x2 Investigational Medical Product's (IMP) and placebo and associated project management. This Contract covers the period from execution of contract (estimated to be August 2018) to supply of final IMPs to last patient (estimated to be September 2020). There will be an option to extend for a further year.
Options: Possible changes/modifications/variations are as follows; - Dose - the millilitre (ml) dosages presented in the tender are indicative and may be subject to change. The nature of this change will be minor and the University will rely on the supplier to recommend a better solution. - Duration - the tender allows for a possible extension of up to 12 months. This is to cover any delays or further patient recruitment. - Stopping a IMP - the nature of this project may render a IMP unusable and as such, the University reserves the right to pull a IMP from the contract. - Introducing a new IMP - the nature of this project, may require a provision to add a new IMP to the trial. Quantities are likely to be similar as detailed in tender (i.e. number of patients), depending on when during the trial the new IMP is introduced. - Sample size - the nature of this project may require the patient sample size of increase or decrease. The University reserves the right to alter this accordingly. None of these amendments are intended to create a new contract.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-r6ebe6-0000570250
- Publication Source
- Public Contracts Scotland
- Latest Notice
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB344636
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- OJEU - F3 - Contract Award Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33698000 - Clinical products
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £261,134 £100K-£500K
Notice Dates
- Publication Date
- 6 Feb 20197 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 5 Feb 20197 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Complete
- Awards Status
- Not Specified
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- UNIVERSITY OF EDINBURGH
- Contact Name
- Not specified
- Contact Email
- sharon.green@ed.ac.uk
- Contact Phone
- +44 1316502508
Buyer Location
- Locality
- EDINBURGH
- Postcode
- EH1 1HT
- Post Town
- Edinburgh
- Country
- Scotland
-
- Major Region (ITL 1)
- TLM Scotland
- Basic Region (ITL 2)
- TLM1 East Central Scotland
- Small Region (ITL 3)
- TLM13 City of Edinburgh
- Delivery Location
- TLM75 City of Edinburgh
-
- Local Authority
- City of Edinburgh
- Electoral Ward
- City Centre
- Westminster Constituency
- Edinburgh East and Musselburgh
Further Information
Notice Documents
-
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB344636
EC0810 Clinical trial formulation, Anne Rowling Clinic - Double blind randomised clinical IMP trial- Manufacture of liquid form of 2 active ingredients and matching placebo, provision of dossier for MHRA application and approval, labelling, storage and distribution of the IMP and placebo as required.
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-r6ebe6-0000570250-2019-02-06T00:00:00Z",
"date": "2019-02-06T00:00:00Z",
"ocid": "ocds-r6ebe6-0000570250",
"initiationType": "tender",
"parties": [
{
"id": "org-25",
"name": "University Of Edinburgh",
"identifier": {
"legalName": "University Of Edinburgh"
},
"address": {
"streetAddress": "Charles Stewart House, 9-16 Chambers Street",
"locality": "Edinburgh",
"region": "UKM75",
"postalCode": "EH1 1HT"
},
"contactPoint": {
"email": "sharon.green@ed.ac.uk",
"telephone": "+44 1316502508",
"url": "http://"
},
"roles": [
"buyer",
"centralPurchasingBody",
"reviewBody"
],
"details": {
"classifications": [
{
"id": "Body governed by public law",
"scheme": "TED_CA_TYPE"
},
{
"id": "09",
"description": "Education",
"scheme": "COFOG"
}
],
"url": "http://www.ed.ac.uk/schools-departments/procurement/supplying"
}
},
{
"id": "org-327",
"name": "Huddersfield Pharmacy Specials",
"identifier": {
"legalName": "Huddersfield Pharmacy Specials"
},
"address": {
"streetAddress": "Gate 2 Acre Mill , School Street West",
"locality": "Huddersfield",
"region": "UKE4",
"postalCode": "HD3 3ET"
},
"contactPoint": {
"telephone": "+44 7967639935"
},
"roles": [
"supplier"
],
"details": {
"scale": "large",
"url": "http://"
}
}
],
"buyer": {
"name": "University Of Edinburgh",
"id": "org-25"
},
"tender": {
"id": "EC0810",
"title": "EC0810 Clinical trial formulation, Anne Rowling Clinic",
"description": "Double blind randomised clinical IMP trial- Manufacture of liquid form of 2 active ingredients and matching placebo, provision of dossier for MHRA application and approval, labelling, storage and distribution of the IMP and placebo as required.",
"status": "complete",
"items": [
{
"id": "1",
"additionalClassifications": [
{
"id": "33698000",
"scheme": "CPV"
}
],
"deliveryLocation": {
"description": "University of Edinburgh Chancellor's Building 49 Little France Crescent Edinburgh EH16 4SB"
},
"deliveryAddresses": [
{
"region": "UKM75"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"mainProcurementCategory": "goods",
"documents": [
{
"id": "FEB344636",
"documentType": "awardNotice",
"title": "EC0810 Clinical trial formulation, Anne Rowling Clinic",
"description": "Double blind randomised clinical IMP trial- Manufacture of liquid form of 2 active ingredients and matching placebo, provision of dossier for MHRA application and approval, labelling, storage and distribution of the IMP and placebo as required.",
"url": "https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=FEB344636",
"format": "text/html"
}
],
"lots": [
{
"id": "1",
"description": "Tender for the manufacturing, packaging, labelling, shipping and storage of x2 Investigational Medical Product's (IMP) and placebo and associated project management. This Contract covers the period from execution of contract (estimated to be August 2018) to supply of final IMPs to last patient (estimated to be September 2020). There will be an option to extend for a further year.",
"status": "complete",
"awardCriteria": {
"criteria": [
{
"type": "quality",
"name": "Quality",
"description": "85"
},
{
"type": "price",
"description": "15"
}
]
},
"options": {
"description": "Possible changes/modifications/variations are as follows; - Dose - the millilitre (ml) dosages presented in the tender are indicative and may be subject to change. The nature of this change will be minor and the University will rely on the supplier to recommend a better solution. - Duration - the tender allows for a possible extension of up to 12 months. This is to cover any delays or further patient recruitment. - Stopping a IMP - the nature of this project may render a IMP unusable and as such, the University reserves the right to pull a IMP from the contract. - Introducing a new IMP - the nature of this project, may require a provision to add a new IMP to the trial. Quantities are likely to be similar as detailed in tender (i.e. number of patients), depending on when during the trial the new IMP is introduced. - Sample size - the nature of this project may require the patient sample size of increase or decrease. The University reserves the right to alter this accordingly. None of these amendments are intended to create a new contract."
},
"hasOptions": true
}
],
"coveredBy": [
"GPA"
],
"classification": {
"id": "33698000",
"scheme": "CPV"
},
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
}
},
"awards": [
{
"id": "EC0810",
"suppliers": [
{
"id": "org-327",
"name": "Huddersfield Pharmacy Specials"
}
],
"relatedLots": [
"1"
]
}
],
"contracts": [
{
"id": "EC0810",
"awardID": "EC0810",
"status": "active",
"value": {
"amount": 261134.56,
"currency": "GBP"
},
"dateSigned": "2019-02-05T00:00:00Z"
}
],
"language": "EN",
"relatedProcesses": [
{
"id": "1",
"relationship": [
"planning"
],
"scheme": "EU-OJ",
"identifier": "2018/S 125-284481"
}
],
"description": "(SC Ref:570250)",
"bids": {
"statistics": [
{
"id": "286",
"measure": "bids",
"value": 5,
"relatedLot": "1"
}
]
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000570250"
}
],
"noticetype": "OJEU - F3 - Contract Award Notice"
}